TY - JOUR
T1 - Precision science on incidence and progression of early-detected small breast invasive cancers by mammographic features
AU - Chang, Rene Wei Jung
AU - Chuang, Shu Lin
AU - Hsu, Chen Yang
AU - Yen, Amy Ming Fang
AU - Wu, Wendy Yi Ying
AU - Chen, Sam Li Sheng
AU - Fann, Jean Ching Yuan
AU - Tabar, Laszlo
AU - Smith, Robert A.
AU - Duffy, Stephen W.
AU - Chiu, Sherry Yueh Hsia
AU - Chen, Hsiu Hsi
N1 - Funding Information:
Funding: This research was funded by the Ministry of Science and Technology (grant number MOST 108-2118-M-002-002-MY3; MOST 107-3017-F-002-003; NSC 102-2314-B-182-028-MY3), the Innovation and Policy Center for Population Health and Sustainable Environment (Population Health Research Center, PHRC) from Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (grant number NTU-107L9003), and partly support from Chang Gung Research Fund (BMRP-B81).
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/7
Y1 - 2020/7
N2 - The aim was to evaluate how the inter-screening interval affected the performance of screening by mammographic appearances. This was a Swedish retrospective screening cohort study with information on screening history and mammography features in two periods (1977–1985 and 1996–2010). The pre-clinical incidence and the mean sojourn time (MST) for small breast cancer allowing for sensitivity by mammographic appearances were estimated. The percentage of interval cancer against background incidence (I/E ratio) was used to assess the performance of mammography screening by different inter-screening intervals. The sensitivity-adjusted MSTs (in years) were heterogeneous with mammographic features, being longer for powdery and crushed stone-like calcifications (4.26, (95% CI, 3.50–5.26)) and stellate masses (3.76, (95% CI, 3.15–4.53)) but shorter for circular masses (2.65, (95% CI, 2.06–3.55)) in 1996–2010. The similar trends, albeit longer MSTs, were also noted in 1977–1985. The I/E ratios for the stellate type were 23% and 32% for biennial and triennial screening, respectively. The corresponding figures were 32% and 43% for the circular type and 21% and 29% for powdery and crushed stone-like calcifications, respectively. Mammography-featured progressions of small invasive breast cancer provides a new insight into personalized quality assurance, surveillance, treatment and therapy of early-detected breast cancer.
AB - The aim was to evaluate how the inter-screening interval affected the performance of screening by mammographic appearances. This was a Swedish retrospective screening cohort study with information on screening history and mammography features in two periods (1977–1985 and 1996–2010). The pre-clinical incidence and the mean sojourn time (MST) for small breast cancer allowing for sensitivity by mammographic appearances were estimated. The percentage of interval cancer against background incidence (I/E ratio) was used to assess the performance of mammography screening by different inter-screening intervals. The sensitivity-adjusted MSTs (in years) were heterogeneous with mammographic features, being longer for powdery and crushed stone-like calcifications (4.26, (95% CI, 3.50–5.26)) and stellate masses (3.76, (95% CI, 3.15–4.53)) but shorter for circular masses (2.65, (95% CI, 2.06–3.55)) in 1996–2010. The similar trends, albeit longer MSTs, were also noted in 1977–1985. The I/E ratios for the stellate type were 23% and 32% for biennial and triennial screening, respectively. The corresponding figures were 32% and 43% for the circular type and 21% and 29% for powdery and crushed stone-like calcifications, respectively. Mammography-featured progressions of small invasive breast cancer provides a new insight into personalized quality assurance, surveillance, treatment and therapy of early-detected breast cancer.
KW - Breast cancer
KW - Interval cancer
KW - Mammography
KW - Sensitivity
KW - Sojourn time
UR - http://www.scopus.com/inward/record.url?scp=85088612989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088612989&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/a6d9362b-b246-3375-8269-5f4d566ecb62/
U2 - 10.3390/cancers12071855
DO - 10.3390/cancers12071855
M3 - Article
AN - SCOPUS:85088612989
SN - 2072-6694
VL - 12
SP - 1
EP - 14
JO - Cancers
JF - Cancers
IS - 7
M1 - 1855
ER -